News
VOV.VN - Prime Minister Pham Minh Chinh has proposed that AstraZeneca consider building a pharmaceutical manufacturing plant ...
Given that the Australian government heavily subsidizes pharmaceuticals— spending more than $AU16.7 billion annually through the Pharmaceutical Benefits Scheme (PBS)—there is both a strong moral and ...
Once hailed as the future of immuno-oncology, it’s been a tough few months for any remaining fans of anti-TIGIT antibodies. | ...
AstraZeneca has signed a deal worth up to $5.2bn to work with a Chinese biotech company using AI to develop new treatments for chronic diseases.
AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which ...
AstraZeneca has signed a research agreement worth more than US$5 billion with Chinese drugmaker CSPC Pharmaceutical Group, ...
Explore more
AstraZeneca has returned to recent licensing partner CSPC Pharmaceuticals with $110 million in upfront cash to start work on ...
Vietnamese Prime Minister Pham Minh Chinh held working sessions with leading Swedish corporations, including Ericsson, H&M, ...
AstraZeneca said it entered into a strategic research collaboration with China's CSPC Pharmaceuticals, focused on artificial intelligence-driven research, valued at up to $5.33 billion.
Drugmaker AstraZeneca revealed on Friday that it has entered a strategic research collaboration with Chinese firm CSPC Pharmaceuticals Group.
Researchers from King's College London have called for urgent changes to the way new antibiotics are developed to address the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results